Managing cardiovascular risk: the need for change.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2017
   Guideline
2. An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
   Article
3. Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2022
   Review
4. Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2018
   Review
5. Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice.Clinical cardiology · 2015
   Review
6. Prevalence of 'borderline' values of cardiovascular risk factors in the clinical practice of general medicine in Italy: results of the BORDERLINE study.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2011
   Article
7. Olmesartan medoxomil for the treatment of hypertension in children and adolescents.Vascular health and risk management · 2011
   Review
8. A literature review of the cardiovascular risk-assessment tools: applicability among Asian population.Heart Asia · 2010
   Article
9. 2008 white paper for implementing strategies and interventions for cardiovascular prevention in Italy.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2008
   Article
10. A New Option for Therapeutic Management of Patients with Cardiovascular Disease : A Closer Look at the ONTARGET Study.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2008
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as